GlucoModicum
PrivateLast Round
VC Round
Jun 17, 2024
Total Funding Raised
$4.47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlucoModicum operates in Healthcare & Life Sciences and is based in Helsinki. Its latest recorded funding round was a VC Round in June 2024.
GlucoModicum is a medical devices company that develops needle-free, continuous glucose monitoring technology using proprietary magnetohydrodynamic (MHD) fluid sampling.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Biotechnology, Clinical Trials
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlucoModicum Comparables
Compare GlucoModicum with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DiaMonTech AG | 89% | |
| RSP Systems A/S | 87% | |
| Transdermal Diagnostics | 87% |
For institutional investors. Book with your work email.
GlucoModicum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 17, 2024 | ||||
| VC Round | Oct 15, 2021 | ||||
| Grant | Jun 16, 2021 | ||||
| Grant | Jan 15, 2020 | ||||
| Seed | May 25, 2019 | ||||
Seed | Sep 13, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GlucoModicum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, VC Round |
| Business Finland | Grant, Seed |
| University of Helsinki | Pre Seed |
| Åbo Akademi University | Pre Seed, Seed |
| EIC Fund | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 174% MoM, reaching 1.3K.
- Jun 17, 2024
LähiTapiola participated in the VC Round.
For institutional investors. Book with your work email.
GlucoModicum Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GlucoModicum's valuation, stock price, and market status.
Is GlucoModicum a public or private company?
GlucoModicum is a private company.
What is the current stock price of GlucoModicum?
GlucoModicum is a private company, so its shares have no public market price. Caplight tracks GlucoModicum's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GlucoModicum worth (valuation)?
Valuation information for GlucoModicum is not publicly available.
Can I buy GlucoModicum stock?
GlucoModicum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GlucoModicum's last funding round?
GlucoModicum's most recent funding round was VC Round on June 17, 2024.
Who are the main investors in GlucoModicum?
Key investors in GlucoModicum include European Innovation Council Fund, EIC Fund.
Will GlucoModicum IPO soon?
No public IPO plans have been announced for GlucoModicum.
How can I track GlucoModicum secondary market activity?
Caplight tracks bids, offers, and trades in GlucoModicum's shares on secondary markets.